Insights

Funding & Revenue With a substantial revenue range of 50 million to 100 million dollars, Ontario Bioscience Innovation Organization presents a significant market opportunity for solutions and services aimed at scaling biotechnological and health tech innovations, as well as supporting early-stage companies in growth phases.

Strong Industry Focus OBIO's emphasis on supporting innovative human health products and startups developing health tech creates procurement and partnership opportunities for companies offering research tools, commercialization platforms, and talent development services tailored to life sciences and biotech sectors.

Strategic Partnerships Collaborations with notable organizations like JLABS, Ontario Securities Commission, and Alberta Health Services highlight OBIO’s active role in fostering industry connections, making it a valuable gateway for sales prospects involving investment platforms, regulatory compliance solutions, and health system integrations.

Funding & Support Programs OBIO’s various initiatives, including health tech training and business development skills programs funded by government grants, indicate opportunities for educational technology providers, consulting firms, and service vendors seeking to support capacity building in the biotech community.

Market Engagement Participation in high-profile events like investment summits and showcases positions OBIO as a strategic partner and influencer within the biotech innovation ecosystem, providing access points for innovative product demos, strategic alliances, and client acquisition opportunities targeting early adopters and startups.

OBIO Tech Stack

OBIO uses 8 technology products and services including Linkedin Insight Tag, RSS, WordPress, and more. Explore OBIO's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • RSS
    Content Management System
  • WordPress
    Content Management System
  • Webpack
    Development
  • Font Awesome
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • Sitelinks Search Box
    Web Tools And Plugins

Media & News

OBIO's Email Address Formats

OBIO uses at least 1 format(s):
OBIO Email FormatsExamplePercentage
FirstLast@obio.caJohnDoe@obio.ca
89%
FirstLas@obio.caJohnDoe@obio.ca
11%

Frequently Asked Questions

What is OBIO's stock symbol?

Minus sign iconPlus sign icon
OBIO is a publicly traded company; the company's stock symbol is OBIO.

What is OBIO's official website and social media links?

Minus sign iconPlus sign icon
OBIO's official website is obio.ca and has social profiles on LinkedIn.

What is OBIO's SIC code NAICS code?

Minus sign iconPlus sign icon
OBIO's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does OBIO have currently?

Minus sign iconPlus sign icon
As of July 2026, OBIO has approximately 27 employees across 4 continents, including North AmericaEuropeAsia. Key team members include Vice President Programs & Strategic Partnerships: C. Y.President And Ceo: M. C.Senior Director Technology Adoption: B. G.. Explore OBIO's employee directory with LeadIQ.

What industry does OBIO belong to?

Minus sign iconPlus sign icon
OBIO operates in the Biotechnology Research industry.

What technology does OBIO use?

Minus sign iconPlus sign icon
OBIO's tech stack includes Linkedin Insight TagRSSWordPressWebpackFont AwesomejQuery MigratejQuerySitelinks Search Box.

What is OBIO's email format?

Minus sign iconPlus sign icon
OBIO's email format typically follows the pattern of FirstLast@obio.ca. Find more OBIO email formats with LeadIQ.

When was OBIO founded?

Minus sign iconPlus sign icon
OBIO was founded in 2009.
OBIO logo

OBIO

Biotechnology ResearchOntario, Canada11-50 Employees

Ontario Bioscience Innovation Organization (OBIO) is a not-for-profit, membership-based entity focused on strategy, programming, policy development, and advocacy to support emerging companies in human health product development. It helps early-stage and venture-backed life sciences and health tech firms raise capital, recruit skilled talent, advance commercialization, and access necessary infrastructure, working through partnerships with industry, investors, academia, the healthcare system, and government. Based in Toronto, Ontario, OBIO operates within the biotechnology research sector and serves organizations aiming to translate scientific advances into health-system adoption and market-ready innovations. Since its founding in 2009, the organization has sought to address the needs of the next generation of health-focused companies through collaboration and programmatic initiatives that bridge industry and capital with public-sector and academic partners. A recent development includes collaboration events and information sessions that connect startups with funders and clarify capital markets regulatory changes to support early-stage growth.

Section iconCompany Overview

Website
obio.ca
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
OBIO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
11-50

Section iconFunding & Financials

  • $50M$100M

    OBIO's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    OBIO's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.